Literature DB >> 7811048

Therapeutic efficacy of lanoconazole, a new imidazole antimycotic agent, for experimental cutaneous candidiasis in guinea pigs.

Y Niwano1, A Seo, K Kanai, H Hamaguchi, K Uchida, H Yamaguchi.   

Abstract

The therapeutic efficacy of 1% cream and 1% solution of lanoconazole, a new imidazole antimycotic agent, in the model of cutaneous candidiasis in prednisolone-treated guinea pigs was evaluated in comparison with that of comparable formulations of bifonazole. Each preparation was topically applied once a day for 3 consecutive days, starting on the fifth day postinfection, and quantitative culture study wsa conducted on the ninth day postinfection. Both formulations of lanoconazole were much more highly effective in terms of eradication of fungi than the bifonazole formulations.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7811048      PMCID： PMC284713          DOI： 10.1128/AAC.38.9.2204

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  5 in total

1.  The bactericidal activity of a methyl and propyl parabens combination: isothermal and non-isothermal studies.

Authors:  D Gilliland; A Li Wan Po; E Scott
Journal:  J Appl Bacteriol       Date:  1992-03

2.  Inhibition by antimicrobial food additives of ochratoxin A production by Aspergillus sulphureus and Penicillium viridicatum.

Authors:  C H Tong; F A Draughon
Journal:  Appl Environ Microbiol       Date:  1985-06       Impact factor: 4.792

3.  Antifungal activity of the new agent latoconazole in two tinea models.

Authors:  T Ohmi; S Konaka; M Uchida; H Yamaguchi
Journal:  Arzneimittelforschung       Date:  1991-08

4.  Changes in the activity of antifungals in mixed cultures of bacteria and yeasts.

Authors:  M H Domon; L G Mathieu; J de Repentigny
Journal:  Can J Microbiol       Date:  1981-08       Impact factor: 2.419

5.  Therapeutic efficacy of latoconazole in formulations of clinical use on experimental dermatophytosis in guinea pigs.

Authors:  H Oka; Y Niwano; T Ohmi; T Tanaka; M Uchida; H Yamaguchi
Journal:  Arzneimittelforschung       Date:  1992-03
  5 in total
  6 in total

Review 1.  An overview of topical antifungal therapy in dermatomycoses. A North American perspective.

Authors:  A K Gupta; T R Einarson; R C Summerbell; N H Shear
Journal:  Drugs       Date:  1998-05       Impact factor: 9.546

2.  In vitro antifungal activity of KP-103, a novel triazole derivative, and its therapeutic efficacy against experimental plantar tinea pedis and cutaneous candidiasis in guinea pigs.

Authors:  Y Tatsumi; M Yokoo; T Arika; H Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

3.  In Vitro Activities of Luliconazole, Lanoconazole, and Efinaconazole Compared with Those of Five Antifungal Drugs against Melanized Fungi and Relatives.

Authors:  Gholam Reza Shokoohi; Hamid Badali; Hossein Mirhendi; Saham Ansari; Ali Rezaei-Matehkolaei; Bahram Ahmadi; Afsane Vaezi; Mohamed Mahdi Alshahni; Koichi Makimura
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

4.  In Vivo Skin Colonization and Decolonization Models for Candida auris.

Authors:  Janet Herrada; Ahmed Gamal; Lisa Long; Mahmoud A Ghannoum
Journal:  Methods Mol Biol       Date:  2022

5.  Short-term topical therapy of experimental tinea pedis in guinea pigs with lanoconazole, a new imidazole antimycotic agent.

Authors:  Y Niwano; T Tabuchi; K Kanai; H Hamaguchi; K Uchida; H Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

Review 6.  Conazoles.

Authors:  Jan Heeres; Lieven Meerpoel; Paul Lewi
Journal:  Molecules       Date:  2010-06-09       Impact factor: 4.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.